// App-Quantinova.ai

3557 : System-based BCL2 family protein signatures as predictive biomarkers in triple-negative breast cancer

Researchers

Presenter

  • Federico Lucantoni

Principal Investigators

  • Andreas U. Lindner

  • Norma ODonovan

  • Damir Vareslija

  • Lance Hudson

  • Arnold DK Hill

  • Michael Kerin

  • Roisin Dwyer

  • Leonie Young

  • Jochen HM Prehn

Medical Centers

  • Royal College of Surgeons in Ireland, Dublin, Ireland

  • National Institute for Cellular Biotechnology, Dublin, Ireland

  • The National University of Ireland, Galway, Ireland

Locations

  • Ireland

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Triple-negative breast cancer

  • B cell lymphomas

  • Breast cancer

  • Lymphomas

  • Solid malignancies

Biomarkers

  • B-cell lymphoma 2

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved